[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic].
Sergey N AvdeevVladimir P ChulanovEkaterina AlexeevaO A AleshinaA V BereznikovO N KotenkoAlexander M LilaZinaida Yu MutovinaElena N ParovichnikovaDarya S FominaN F FrolovaA O ShevchenkoPublished in: Terapevticheskii arkhiv (2023)
On July 3, 2023, an interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic realities" was held in Moscow with leading experts in pulmonology, rheumatology, hematology, oncology, nephrology, allergology-immunology, transplantation, and infectious diseases. The aim of the meeting was to discuss the current clinical and epidemiologic situation related to COVID-19, the relevance of disease prevention strategies for high-risk patients. The experts addressed the following issues: 1) the disease burden of COVID-19 in 2023 for patients with immunodeficiency in different therapeutic areas; 2) the place of passive immunization with monoclonal antibodies as a method of COVID-19 prophylaxis among immunocompromised patients; 3) prerequisites for the inclusion of passive immunization of immunocompromised patients into routine clinical practice.
Keyphrases
- end stage renal disease
- coronavirus disease
- sars cov
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical practice
- peritoneal dialysis
- prognostic factors
- systemic lupus erythematosus
- infectious diseases
- patient reported outcomes
- bone marrow
- risk factors
- mesenchymal stem cells
- extracorporeal membrane oxygenation
- respiratory syndrome coronavirus
- respiratory failure